## Core Concept
The question tests the understanding of pharmacological effects of certain compounds on central nervous system (CNS) neurotransmitters and their potential to cause extrapyramidal side effects. The compound in question affects dopamine, adrenaline, and serotonin, and at high doses, can lead to Parkinsonism-like symptoms, which are typically associated with dopamine depletion or blockade in the nigrostriatal pathway.

## Why the Correct Answer is Right
The correct answer, , is known to be a typical antipsychotic. Typical antipsychotics are dopamine D2 receptor antagonists. By blocking dopamine receptors, they decrease the functional activity of dopamine. Since dopamine is crucial for the regulation of movement, blocking its action can lead to extrapyramidal side effects (EPS), including Parkinsonism. These drugs also affect other neurotransmitter systems, such as serotonin and norepinephrine (adrenaline), which can contribute to their therapeutic and side effect profiles.

## Why Each Wrong Option is Incorrect
- **Option A:** is an atypical antipsychotic. Atypical antipsychotics have a lower propensity to cause EPS compared to typical antipsychotics because they have a higher ratio of serotonin to dopamine receptor antagonism. While they can affect dopamine, their side effect profile regarding EPS is generally more favorable.
- **Option B:** is not commonly associated with significant dopamine receptor antagonism leading to EPS. Its primary use and side effect profile do not align well with the description given.
- **Option C:** does not directly correspond with a well-known antipsychotic or a compound commonly associated with the described effects on neurotransmitters and EPS.

## Clinical Pearl / High-Yield Fact
A key point to remember is that typical antipsychotics are more likely to cause extrapyramidal side effects (EPS) such as Parkinsonism due to their potent dopamine D2 receptor antagonism. A classic clinical correlation is that patients on typical antipsychotics may require anticholinergic medications to mitigate EPS.

## Correct Answer Line
**Correct Answer: D. **